Integrating Network Pharmacology with in vitro Experiments to Validate the Efficacy of Celastrol Against Hepatocellular Carcinoma Through Ferroptosis
Banglan Cai,1,2,* Manman Qi,2,3,* Xue Zhang,1,2 Denghai Zhang1- 3 1School of Basic Medicine, Ningxia Medical University, Yinchuan, People's Republic of China; 2Shanghai Health Commission Key Laboratory of Artificial Intelligence (AI)-Based Management of Inflammation and Chronic...
Saved in:
Main Authors: | Cai B (Author), Qi M (Author), Zhang X (Author), Zhang D (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic engineering of celastrol liposomes induces ferroptosis and apoptosis by directly targeting VDAC2 in hepatocellular carcinoma
by: Piao Luo, et al.
Published: (2023) -
Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and In Vitro Experiments
by: Xuan Wang, et al.
Published: (2022) -
Mechanisms of dihydromyricetin against hepatocellular carcinoma elucidated by network pharmacology combined with experimental validation
by: Shuo Zhang, et al.
Published: (2023) -
Mechanisms underlying the activity of paederus in hepatocellular carcinoma: A network pharmacology and in vitro validation approach
by: Li shan, et al.
Published: (2022) -
Integrating Network Pharmacology and Bioinformatics to Explore the Effects of Dangshen (Codonopsis pilosula) Against Hepatocellular Carcinoma: Validation Based on the Active Compound Luteolin
by: Yu Y, et al.
Published: (2023)